Bivalirudin

Product manufactured by Sandoz Inc

Application Nr Approved Date Route Status External Links
NDA020873 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Bivalirudin For Injection Is Indicated For Use As An Anticoagulant For Use In Patients Undergoing Percutaneous Coronary Intervention (Pci) Including Patients With Heparin-Induced Thrombocytopenia And Heparin-Induced Thrombocytopenia And Thrombosis Syndrome. Bivalirudin For Injection Is A Direct Thrombin Inhibitor Indicated For Use As An Anticoagulant In Patients Undergoing Percutaneous Coronary Intervention (Pci) Including Patients With Heparin-Induced Thrombocytopenia (Hit) Or Heparin-Induced Thrombocytopenia And Thrombosis Syndrome (Hitts).( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bivalirudin

Comments